[HTML][HTML] Assessing the safety and efficacy of TAVR compared to SAVR in low-to-intermediate surgical risk patients with aortic valve stenosis: An overview of reviews

R Mc Morrow, C Kriza, P Urban, V Amenta… - International journal of …, 2020 - Elsevier
Background Transcatheter aortic valve replacement (TAVR) was initially introduced to treat
patients with aortic valve stenosis (AS) at high-risk for surgical aortic valve replacement …

Temporal validation of 30-day mortality prediction models for transcatheter aortic valve implantation using statistical process control–An observational study in a …

RR Lopes, TTR Yordanov, ACJ Ravelli, S Houterman… - Heliyon, 2023 - cell.com
Background Various mortality prediction models for Transcatheter Aortic Valve Implantation
(TAVI) have been developed in the past years. The effect of time on the performance of such …

Comparison of transcatheter aortic valve implantation devices in aortic stenosis: a network meta-analysis of 42,105 patients

AA Dogosh, A Adawi, A El Nasasra, C Cafri… - Journal of Clinical …, 2022 - mdpi.com
Background: In recent years, trans-catheter aortic valve implantation (TAVI) has emerged as
an excellent alternative to surgical aortic valve replacement (SAVR). Currently, there are …

Neurological outcomes of transcatheter aortic valve implantation with or without cerebral embolic protection devices: A meta-analysis

D Perez-Camargo, A Travieso… - Journal of Stroke and …, 2022 - Elsevier
Introduction Cerebral embolic protection devices (CEPDs) are designed to prevent
embolization of debris during transcatheter aortic valve implantation (TAVI). Current …

[HTML][HTML] Update and, internal and temporal-validation of the FRANCE-2 and ACC-TAVI early-mortality prediction models for Transcatheter aortic Valve Implantation …

H Al-Farra, BAJM de Mol, ACJ Ravelli, W Ter Burg… - IJC Heart & …, 2021 - Elsevier
Background The predictive performance of the models FRANCE-2 and ACC-TAVI for early-
mortality after Transcatheter Aortic Valve Implantation (TAVI) can decline over time and can …

[HTML][HTML] Predictors of mortality in patients with transcatheter aortic valve implantation: a national inpatient sample database analysis

A Inayat, S Abbas, FNU Salman - Cureus, 2021 - ncbi.nlm.nih.gov
Methods The National Inpatient Sample database from the year 2011 to 2018 was used to
identify all patients undergoing TAVI during the study period. Results A total of 215,983 …

[PDF][PDF] Machine Learning Prediction Models of Optimal Time for Aortic Valve Replacement in Asymptomatic Patients.

S Alzghoul, O Smadi, A Al Bataineh… - … Automation & Soft …, 2023 - researchgate.net
Currently, the decision of aortic valve replacement surgery time for asymptomatic patients
with moderate-to-severe aortic stenosis (AS) is made by healthcare professionals based on …

Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across …

JPW Himmels, SA Flottorp, AK Stoinska-Schneider… - 2021 - fhi.brage.unit.no
The Ordering Forum RHF commissioned in August 2019, through the National System for
Managed Introduction of New Health Technologies within the Specialist Health Service in …

Long-term follow-up of transcatheter aortic valve implantation with Portico versus Evolut devices

N Corcione, G Biondi-Zoccai, P Ferraro… - The American Journal of …, 2020 - Elsevier
New-generation devices such as Evolut and Portico have provided favorable results in
patients who underwent transcatheter aortic valve implantation (TAVI) for aortic stenosis, but …

Beyond the ten-year horizon: long-term outcome of patients undergoing TAVR with first-generation devices

SN Lochbihler - 2023 - mediatum.ub.tum.de
The objective of this study was to evaluate longterm outcomes of TAVR in high-risk patients
with a follow-up of over 10 years. The focus was on survival, structural valve deterioration …